Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (ISThe goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatmen

read more>>

UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has received notification from the U.S. Food & Drug Administration (FDA) that the PDUFA date for Questcor's supplemental new drug application (sNDA) to approve Acthar for the treatment of infantile The

read more>>

BLOOMINGTON, Minn. -- The Child Neurology Foundation (CNF) today announced that $30,000 was raised during Infantile Spasms Awareness Week (October 11-17) that will go towards researching the cause and treatment of this ultra-rare form of epilepsy.

read more>>

A"Benefit for Natalie" will be held Oct. 24 from 3 to 7 p.m. at the Headliner in Neptune. The event will be an afternoon of fun for the entire family.Natalie is the 4-year-old daughter of a 13-year veteran of the Howell Police Department who has suffered from seizures since birth.

read more>>

A "Benefit for Natalie" will be held on Oct. 24 from 3-7 p.m. at the Headliner in Neptune. The event will be an afternoon of fun for the entire family.Natalie is the 4-year-old daughter of a 13- year veteran of the Howell Police Department. She has had seizures since birth.At 4 months old, Natalie was diagnosed with infantile spasms, a rare seizure disorder. This requires Natalie to…

read more>>

She joined in a world trial of a new drug after being diagnosed with a form of infantile spasms called West's Syndrome.Kilian, 34, and Emily Hall, 39, from West Hill, near Ottery St Mary, Devon, were told about the condition, which affects around 400 children in the UK each year, affecting one in every 5,000 births, when she was six months old.Around 90 per cent of children affected suffer mental…

read more>>

UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has joined with the Child Neurology Foundation (CNF) to officially support the creation of Infantile Spasms (IS) Awareness Week. The first annual IS Awareness Week will take place the week of October 11-17, 2009, in conjunction with the Child Neurology Society (CNS) Annual Meeting in Louisville, Kentucky…

read more>>

Four months after Allie Jacobs was born her seizures began."Both arms would go out to her side and her little body would suddenly go into a crunch-like position, usually after waking," explains her dad.These seemingly involuntary movements often came in clusters or waves, sometimes up to five to 10 at a time - a frightening ordeal for any parent. Her parents felt helpless.

read more>>

UNION CITY, Calif. -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced that it has completed its filing to the U.S. Food & Drug Administration (FDA) for its supplemental New Drug Application (sNDA) seeking approval to market H.P. Acthar(r) Gel (repository corticotrophin injection) for the treatment of infantile spasms. In June 2006 Questcor submitted a sNDA to the FDA and in May 2007…

read more>>

Shares of Questcor Pharmaceuticals Inc. fell Wednesday after the company said the regulatory process for expanded approval of the drug Acthar is taking longer than expected.The comments, from President and Chief Executive Don Bailey, came late Tuesday during a conference call to discuss the company's fourth-quarter and 2008 profit results.Shares plunged $1.36, or 20 percent, to close at $5.44.…

read more>>